Pricing Log in Create free account

QIAGEN N.V. (QGEN) vs Sotera Health Company (SHC)

QIAGEN N.V. and Sotera Health Company are both Diagnostics & Research companies. QIAGEN N.V. is the larger, with a market value of $9.5B against $5.2B — 1.8× the size. QIAGEN N.V. trades at the lower P/E: 23.6× against 31.4×. Sotera Health Company grew revenue faster over the last twelve months: 8.15% against 2.96%. QIAGEN N.V. has the higher net margin (19.5% vs 13.4%) and the lower return on invested capital (6.62% vs 9.82%). Across the 22 metrics below, QIAGEN N.V. leads on 15 and Sotera Health Company on 7.

Valuation

Metric QGEN SHC Diagnostics & Research median
P/E 23.64 31.39 35.56
P/S 4.53 4.20 4.37
P/B 2.83 7.68 3.06
Price to free cash flow 21.60 45.36 35.76
EV/EBITDA 15.93 13.18 24.35
EV/Sales 4.94 5.74 5.51
Earnings yield 4.23% 3.19% (1.89%)
Free cash flow yield 4.63% 2.20% (0.15%)

Profitability

Metric QGEN SHC Diagnostics & Research median
Gross margin 62.20% 54.97% 50.89%
Operating margin 21.21% 32.82% (8.57%)
Net margin 19.49% 13.44% (6.37%)
Free cash flow margin 20.98% 9.27% 0.00%
Return on equity 11.93% 27.78% (2.92%)
Return on assets 6.99% 5.01% (6.71%)
Return on invested capital 6.62% 9.82% 0.00%

Growth

Metric QGEN SHC Diagnostics & Research median
Revenue growth (TTM) 2.96% 8.15% 7.69%
EPS growth (last fiscal year) 398.07% 68.75% 25.92%
Revenue growth, 5-year CAGR 2.25% 7.30% 7.40%
Net income growth, 5-year CAGR 3.42% 0.00% 0.00%

Health

Metric QGEN SHC Diagnostics & Research median
Debt to equity 0.49 3.35 0.11
Current ratio 2.85 2.80 2.02
Net debt to EBITDA 0.84 3.74 0.70

Dividend

Metric QGEN SHC Diagnostics & Research median
Dividend yield 0.76% — 0.66%
Payout ratio 0.18 — 0.20

Size

Metric QGEN SHC Diagnostics & Research median
Market cap 9.51b 5.16b 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack